Quotes 5-day view Delayed Nasdaq
01/14/2021
01/15/2021
01/19/2021
01/20/2021
01/21/2021
Date
17.14(c)
16.78(c)
16.94(c)
16.71(c)
16.63(c)
Last
145 641
62 447
93 940
80 096
116 449
Volume
-0.81% -2.10% +0.95% -1.36% -0.48% Change
Sales 2020
155 M - -
Net income 2020
-39,7 M - -
Net Debt 2020
-
-
-
P/E ratio 2020
-11,4x
Yield 2020
-
Sales 2021
184 M - -
Net income 2021
-26,4 M - -
Net Debt 2021
-
-
-
P/E ratio 2021
-17,7x
Yield 2021
-
Capitalization
460 M 460 M -
Capi. / Sales 2020
2,97x
Capi. / Sales 2021
2,50x
Nbr of Employees
386
Free-Float
87,4%
SeaSpine Holdings Corporation is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company offers a portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the...
Notations Surperformance© of SeaSpine Holdings Corporation
Trading Rating : Investor Rating :
All news about SEASPINE HOLDINGS CORPORATION
News in other languages on SEASPINE HOLDINGS CORPORATION
Chart SEASPINE HOLDINGS CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SEASPINE HOLDINGS CORPORATION
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
8
Average target price
20,28 $
Last Close Price
16,63 $
Spread / Highest target
39,8%
Spread / Average Target
22,0%
Spread / Lowest Target
-9,80%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
